Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mismatched donor cell infusion-related syndrome following microtransplant in patients with acute myeloid leukemia. | Chin Med J (Engl) | 2023 | 37027433 | PubTator, text mining | PubMed |
| Repeated spontaneous remission of acute myeloid leukemia in response to various infections: a case report. | BMC Infect Dis | 2023 | 37024850 | PubTator, text mining | PubMed |
Avapritinib is effective for treatment of minimal residual disease in acute myeloid leukemia with t (8;21) and kit mutation failing to immunotherapy after allogeneic hematopoietic stem cell transplantation. | Bone Marrow Transplant | 2023 | 37024571 | PubTator, text mining | PubMed |
| Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication. | Nat Commun | 2023 | 37019972 | PubTator, text mining | PubMed |
| TMT-based comprehensive proteomic profiling identifies serum prognostic signatures of acute myeloid leukemia. | Open Med (Wars) | 2023 | 37016705 | PubTator, text mining | PubMed |
| Frequency and pattern of chromosomal abnormalities in acute myeloid leukemia from Western India: A retrospective study. | J Cancer Res Ther | 2023 | 37006070 | PubTator, text mining | PubMed |
| T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo. | Pharmaceutics | 2023 | 36986589 | PubTator, text mining | PubMed |
| Deciphering Selectivity Mechanism of BRD9 and TAF1(2) toward Inhibitors Based on Multiple Short Molecular Dynamics Simulations and MM-GBSA Calculations. | Molecules | 2023 | 36985555 | PubTator, text mining | PubMed |
| Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research. | Int J Mol Sci | 2023 | 36982453 | PubTator, text mining | PubMed |
| The Relevance of Telomerase and Telomere-Associated Proteins in B-Acute Lymphoblastic Leukemia. | Genes (Basel) | 2023 | 36980962 | PubTator, text mining | PubMed |
| Optical Genome Mapping Reveals and Characterizes Recurrent Aberrations and New Fusion Genes in Adult ALL. | Genes (Basel) | 2023 | 36980958 | PubTator, text mining | PubMed |
| Propagated Circulating Tumor Cells Uncover the Potential Role of NFκB, EMT, and TGFβ Signaling Pathways and COP1 in Metastasis. | Cancers (Basel) | 2023 | 36980717 | PubTator, text mining | PubMed |
| Deregulated Gene Expression Profiles and Regulatory Networks in Adult and Pediatric RUNX1/RUNX1T1-Positive AML Patients. | Cancers (Basel) | 2023 | 36980682 | PubTator, text mining | PubMed |
| Polycomb Alterations in Acute Myeloid Leukaemia: From Structure to Function. | Cancers (Basel) | 2023 | 36980579 | PubTator, text mining | PubMed |
| A Successful Bridge Therapy Combining Hypomethylating Agents with Venetoclax for Adult Patients with Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia. | Cancers (Basel) | 2023 | 36980551 | PubTator, text mining | PubMed |
| Telomere Transcription in MLL-Rearranged Leukemia Cell Lines: Increased Levels of TERRA Associate with Lymphoid Lineage and Are Independent of Telomere Length and Ploidy. | Biomedicines | 2023 | 36979904 | PubTator, text mining | PubMed |
| Effects of the Acetyltransferase p300 on Tumour Regulation from the Novel Perspective of Posttranslational Protein Modification. | Biomolecules | 2023 | 36979352 | PubTator, text mining | PubMed |
| A ciprofloxacin derivative with four mechanisms of action overcomes paclitaxel resistance in p53-mutant and MDR1 gene-expressing type II human endometrial cancer. | Biomaterials | 2023 | 36965280 | PubTator, text mining | PubMed |
| Acute pancreatitis as the initial manifestation of acute myeloid leukemia with chromosome 16 rearrangements. | Int J Hematol | 2023 | 36964839 | PubTator, text mining | PubMed |
| Prediction model for drug response of acute myeloid leukemia patients. | NPJ Precis Oncol | 2023 | 36964195 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=19